The Hematology-Oncology Fellowship Training Program at Washington University School of Medicine is an ACGME-accredited, 3-year program with 18 fellows, accepting 6 new fellows per year. It is designed to attract outstanding physicians and train them for academic careers in the fields of hematology and/or oncology.
The Fellowship Program offers clinical and research training in hematology and oncology and is administered jointly by the Divisions of Hematology and Oncology in the Department of Medicine. The training faculty for the Divisions includes approximately 90 full-time academic investigators.
The University offers a flexible program that provides trainees with comprehensive exposure to the various disciplines of hematology and oncology and accommodates their specific interests. A balance is sought between providing a sound clinical understanding of hematologic and malignant diseases and providing the environment for creative clinical or laboratory-based research into fundamental problems.
Incoming fellows have the opportunity to choose between three tracks: the Clinical Provider Track, the Clinical Investigator Track, and the Laboratory Investigator Track. The first year for all tracks is nearly identical and consists of 50% inpatient and 50% outpatient rotations. Details regarding year 2 and beyond for each track are outlined below.
Clinical Provider Track
The second and third years of the Clinical Provider Track are designed to allow clinical fellows to complete requirements necessary for double- or single- boarding in hematology and/or oncology. Fellows follow a disease-specific curriculum that requires 5 half-day outpatient clinics per week, 20% of which are in elective specialties. When not on clinical rotations, fellows are given time to pursue scholarly activities, including clinical and translational research protocol development/implementation/data analysis and preparing articles for publication. This track is designed for fellows intending to enter community practice.
Clinical Investigator Track
The Clinical Investigator Track is similar to the Clinical Provider Track in structure, but requires less clinical responsibility and increased research/scholarly activity in years 2 and 3. Fellows on this track follow a disease-specific curriculum and that requires 4 half-day outpatient clinics per week, 50% of which are in elective specialties. They are also expected to produce additional scholarly work. The curriculum prepares the fellow to double- or single-board in hematology and/or oncology. This track is designed for fellows intending to enter into academic clinical research.
Laboratory Research Track
For fellows on the Laboratory Research Track, the second and third years are designated as protected research time. Laboratory fellows are not required to do any further clinical rotations (unless seeking to double-board), but will have one half-day per week of continuity clinic. Fellows that are on an ABIM-approved Research Pathway complete one additional year of laboratory training.
Alumni 2005-2016: Post-Graduation Employment
The fellowship program has trained over 200 clinical fellows and numerous graduate and post-doctoral research fellows. Of these, twenty-five have become Hematology directors at medical schools or at the National Institutes of Health (NIH); five have been appointed chairs of Departments of Medicine; and one has been appointed dean of a medical school.
Alumni 2005-2015: ABIM Subspecialty Certification
All Oncology-boarding fellows take the ASCO in-training examination annually, and all Hematology-boarding fellows take the ASH in-service examination annually. Our fellows historically score highly on these exams. In 2016, our program placed 96th percentile on the ASCO exam and 85th percentile on the ASH exam.